| Paracetamol crystallization using laser backscattering and ATR-FTIR spectroscopy: metastability, agglomeration, and control M Fujiwara, PS Chow, DL Ma, RD Braatz Crystal Growth & Design 2 (5), 363-370, 2002 | 347 | 2002 |
| Polymorphism in cocrystals: a review and assessment of its significance S Aitipamula, PS Chow, RBH Tan CrystEngComm 16 (17), 3451-3465, 2014 | 320 | 2014 |
| Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs S Aitipamula, PS Chow, RBH Tan CrystEngComm 11 (9), 1823-1827, 2009 | 175 | 2009 |
| Recent advances in crystallization control: an industrial perspective ZQ Yu, JW Chew, PS Chow, RBH Tan Chemical Engineering Research and Design 85 (7), 893-905, 2007 | 166 | 2007 |
| Simulation of mixing effects in antisolvent crystallization using a coupled CFD-PDF-PBE approach XY Woo, RBH Tan, PS Chow, RD Braatz Crystal Growth & Design 6 (6), 1291-1303, 2006 | 164 | 2006 |
| Effects of operating conditions on agglomeration and habit of paracetamol crystals in anti-solvent crystallization ZQ Yu, RBH Tan, PS Chow Journal of Crystal Growth 279 (3-4), 477-488, 2005 | 143 | 2005 |
| Polymorphs and solvates of a cocrystal involving an analgesic drug, ethenzamide, and 3, 5-dinitrobenzoic acid S Aitipamula, PS Chow, RBH Tan Crystal growth & design 10 (5), 2229-2238, 2010 | 142 | 2010 |
| Steam-assisted solid wet-gel synthesis of high-quality nanorods of boehmite and alumina SC Shen, Q Chen, PS Chow, GH Tan, XT Zeng, Z Wang, RBH Tan The Journal of Physical Chemistry C 111 (2), 700-707, 2007 | 132 | 2007 |
| Novel solid forms of the anti-tuberculosis drug, Isoniazid: ternary and polymorphic cocrystals S Aitipamula, ABH Wong, PS Chow, RBH Tan CrystEngComm 15 (29), 5877-5887, 2013 | 124 | 2013 |
| Characterization, physicochemical and photo-stability of a co-crystal involving an antibiotic drug, nitrofurantoin, and 4-hydroxybenzoic acid VR Vangala, PS Chow, RBH Tan CrystEngComm 13 (3), 759-762, 2011 | 120 | 2011 |
| Acceleration of crystal growth rates: an unexpected effect of tailor-made additives R Dowling, RJ Davey, RA Curtis, G Han, SK Poornachary, PS Chow, ... Chemical communications 46 (32), 5924-5926, 2010 | 116 | 2010 |
| Operating regions in cooling cocrystallization of caffeine and glutaric acid in acetonitrile ZQ Yu, PS Chow, RBH Tan Crystal growth & design 10 (5), 2382-2387, 2010 | 112 | 2010 |
| Dimorphs of a 1: 1 cocrystal of ethenzamide and saccharin: solid-state grinding methods result in metastable polymorph S Aitipamula, PS Chow, RBH Tan CrystEngComm 11 (5), 889-895, 2009 | 100 | 2009 |
| Co-crystals and co-crystal hydrates of the antibiotic nitrofurantoin: structural studies and physicochemical properties VR Vangala, PS Chow, RBH Tan Crystal growth & design 12 (12), 5925-5938, 2012 | 96 | 2012 |
| Molecular simulation study of the effect of various additives on salbutamol sulfate crystal habit Y Yani, PS Chow, RBH Tan Molecular pharmaceutics 8 (5), 1910-1918, 2011 | 93 | 2011 |
| Direct precipitation of micron-size salbutamol sulfate: new insights into the action of surfactants and polymeric additives S Xie, SK Poornachary, PS Chow, RBH Tan Crystal growth & design 10 (8), 3363-3371, 2010 | 92 | 2010 |
| Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery S Shen, PS Chow, F Chen, RBH Tan Chemical and pharmaceutical bulletin 55 (7), 985-991, 2007 | 88 | 2007 |
| Conformational polymorphism of tolbutamide: a structural, spectroscopic, and thermodynamic characterization of Burger’s forms I–IV S Thirunahari, S Aitipamula, PS Chow, RBH Tan Journal of pharmaceutical sciences 99 (7), 2975-2990, 2010 | 87 | 2010 |
| Pharmaceutical cocrystals of ethenzamide: structural, solubility and dissolution studies S Aitipamula, ABH Wong, PS Chow, RBH Tan CrystEngComm 14 (24), 8515-8524, 2012 | 86 | 2012 |
| Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy Y Li, PS Chow, RBH Tan International journal of pharmaceutics 415 (1-2), 110-118, 2011 | 85 | 2011 |
